We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $27.8B Turnover 30.15%
1-Year Est. Return 46.46%
 

Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.

This Fund
S&P 500
This Quarter Est. Return
+31.84%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$27.8B
AUM Growth
+$4.02B
Cap. Flow
-$324M
Cap. Flow %
-1.17%
Top 10 Hldgs %
27.66%
Holding
1,111
New
158
Increased
319
Reduced
438
Closed
177
Avg Time Held
2.1 years
Top 10 Avg Time Held
4.2 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$325M
2
CRWD icon
CrowdStrike
CRWD
+$225M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$186M
4
SNDK icon
Sandisk
SNDK
+$155M
5
SYY icon
Sysco
SYY
+$147M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$418M
2
NOW icon
ServiceNow
NOW
+$262M
3
AAPL icon
Apple
AAPL
+$260M
4
MAS icon
Masco
MAS
+$163M
5
ROKU icon
Roku
ROKU
+$139M

Sector Composition

Rank Sector Weight
1 Technology 33.14%
2 Financials 13.01%
3 Consumer Discretionary 12.82%
4 Industrials 11.2%
5 Healthcare 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AVIR icon
951
Atea Pharmaceuticals
AVIR
$345M
– –
-43,104
Closed -$232K –
AVO icon
952
Mission Produce
AVO
$1.04B
– –
-107,282
Closed -$1.48M –
AVPT icon
953
AvePoint
AVPT
$3.48B
– –
-186,445
Closed -$1.77M –
AVT icon
954
Avnet
AVT
$6.91B
– –
-3,546
Closed -$219K –
AXTI icon
955
AXT Inc
AXTI
$2.74B
– –
-13,438
Closed -$766K –
AYI icon
956
Acuity Brands
AYI
$9.9B
– –
-66,251
Closed -$18.6M –
BALL icon
957
Ball Corp
BALL
$17B
– –
-64,083
Closed -$3.79M –
BAND icon
958
Bandwidth Inc
BAND
$1.42B
– –
-180,619
Closed -$3.22M –
BC icon
959
Brunswick
BC
$4.89B
– –
-30,483
Closed -$2.22M –
BCRX icon
960
BioCryst Pharmaceuticals
BCRX
$1.96B
– –
-1,004,373
Closed -$9.6M –
BHE icon
961
Benchmark Electronics
BHE
$2.25B
– –
-24,072
Closed -$1.35M –
BHVN icon
962
Biohaven
BHVN
$2.09B
– –
-30,080
Closed -$254K –
BLD icon
963
DELISTED
TopBuild
BLD
– –
-653
Closed -$229K –
BLZE icon
964
Backblaze
BLZE
$489M
– –
-174,576
Closed -$602K –
BMEA icon
965
Biomea Fusion
BMEA
$42.3M
– –
-310,514
Closed -$475K –
BR icon
966
Broadridge
BR
$21.8B
– –
-3,246
Closed -$527K –
BW icon
967
Babcock & Wilcox
BW
$663M
– –
-13,639
Closed -$200K –
CCRN icon
968
DELISTED
Cross Country Healthcare
CCRN
– –
-617,010
Closed -$5.8M –
CDLX icon
969
Cardlytics
CDLX
$8.18M
– –
-5,310
Closed -$55.8K –
CI icon
970
Cigna
CI
$78.3B
– –
-49,979
Closed -$13.3M –
CMCO icon
971
Columbus McKinnon
CMCO
$599M
– –
-68,710
Closed -$998K –
CME icon
972
CME Group
CME
$114B
– –
-35,414
Closed -$10.5M –
CMPX icon
973
Compass Therapeutics
CMPX
$139M
– –
-30,655
Closed -$162K –
CNP icon
974
CenterPoint Energy
CNP
$27.3B
– –
-455,872
Closed -$19.7M –
CRAI icon
975
CRA International
CRAI
$1.29B
– –
-8,184
Closed -$1.32M –

Similar funds

Jacobs Levy Equity Management's Q2 2026 Portfolio in Review

As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
  • Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
  • Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
  • Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
  • Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
  • Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
  • Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.